Management of no-reflow phenomenon in the catheterization laboratory

SH Rezkalla, RV Stankowski, J Hanna… - JACC: Cardiovascular …, 2017 - jacc.org
no-reflow during ST-segment elevation myocardial infarction (… In the era of reperfusion in
the 1980s, the pathophysiological … in acute myocardial infarction". Angiology 2015; 66: 644. …

The significance of microthrombosis and fgl2 in no-reflow phenomenon of rats with acute myocardial ischemia/reperfusion

L Shao, D Wu, P Zhang, W Li, J Wang… - Clinical and Applied …, 2013 - journals.sagepub.com
… In conclusion, this study demonstrates that microthrombosis is involved in no-reflow
phenomenon and fgl2 should be a potential predictor of the occurrence of no-reflow phenomenon. …

5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction

G Ndrepepa, K Tiroch, M Fusaro, D Keta… - Journal of the American …, 2010 - jacc.org
… of no-reflow phenomenon on 5-year mortality among patients with acute ST-segment elevation
myocardial infarction (… of reperfusion in acute myocardial infarction by myocardial blush …

Evaluating the 'no reflow'phenomenon with myocardial contrast echocardiography

S Kaul - Basic research in cardiology, 2006 - Springer
… thrombolysis in myocardial infarction (TIMI) grade 3 flow have evidence of tissue no reflow
based … Thus, early after attempted reperfusion, the no reflow zone can include regions of the …

No-reflow: again prevention is better than treatment

G Niccoli, RK Kharbanda, F Crea… - European heart …, 2010 - academic.oup.com
… is unique in that it can also be applied during myocardial ischaemia prior to reperfusion.
In a recent … in the adenosine A2 receptor and angiographic no-reflow phenomenon (abstr) …

Clinical significance of no-reflow phenomenon observed on angiography after successful treatment of acute myocardial infarction with percutaneous transluminal …

I Morishima, T Sone, S Mokuno, S Taga… - American heart …, 1995 - Elsevier
… 22 during early reperfusion period reduces the no-reflow phenomenon and infarct size.
Treatment with a nitric oxide precursor also improves nitric oxide--dependent vasodilation of the …

[HTML][HTML] The noreflow phenomenon in coronary arteries

RV Kelly, MG Cohen, MS Runge, GA Stouffer - Journal of thrombosis and …, 2004 - Elsevier
… Kern have suggested classifying noreflow into ‘experimental noreflow’, ‘MI reperfusion
treatment of acute myocardial infarction, abciximab reduced noreflow in patients randomized …

A role for pericytes in coronary no-reflow

FM O'farrell, D Attwell - Nature reviews cardiology, 2014 - nature.com
… The similarity of the no-reflow phenomenon in the brain and in … target for coronary no-reflow
after myocardial infarction. … of myocardial stunning, reperfusion arrhythmias, no-reflow, and …

[PDF][PDF] Role of adenosine as an adjunct therapy in the prevention and treatment of no-reflow phenomenon in acute myocardial infarction with ST segment elevation …

M Grygier, A Araszkiewicz, M Lesiak… - … Polska (Polish Heart …, 2013 - journals.viamedica.pl
… in microcirculation of the reperfused bed [1]… ‘no-reflow phenomenon’) and no-reflow appears
to be an important component of the potential deleterious effect of reperfusionmyocardial

Microvascular Obstruction: The No-Reflow Phenomenon in Animal Models of Myocardial Ischemia and Reperfusion

T Reffelmann, RA Kloner - Management of Myocardial Reperfusion Injury, 2012 - Springer
… Infarct size appears to be the major determinant of the occurrence and degree of no-reflow
in many animal models of myocardial infarction and also in clinical circumstances. In the early …